[Federal Register Volume 61, Number 242 (Monday, December 16, 1996)]
[Notices]
[Page 66052]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-31948]


-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

Board of Scientific Counselors, National Institute for 
Occupational Safety and Health: Announcement of Meeting and Request for 
Comments on Diesel Exhaust Study Protocol

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting:

    Name: Board of Scientific Counselors, National Institute for 
Occupational Safety and Health (BSC, NIOSH).
    Time and Date: 9 a.m.-5 p.m., January 14, 1997.
    Place: The Washington Court Hotel, Montpelier Room, 525 New 
Jersey Avenue NW, Washington, DC 20001.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 50 people.
    Purpose: The BSC, NIOSH is charged with providing advice to the 
Director, NIOSH on NIOSH research programs. Specifically, the Board 
shall provide guidance on NIOSH's research activities related to 
developing and evaluating hypotheses, systematically documenting 
findings, and disseminating results.
    Matters to be Discussed: Agenda items include a report from the 
Director of NIOSH and reports on the January NIOSH/OSHA effective 
ergonomic practices conference; NIOSH construction and agriculture 
programs; women's safety and health at work; the National 
Occupational Research Agenda; review of the Health Hazard Evaluation 
Program; and future activities of the Board.
    In addition, the Board will consider the August 1995 draft 
protocol for the NIOSH/National Cancer Institute (NCI) study 
entitled ``A Cohort Mortality Study With a Nested Case-Control Study 
of Lung Cancer and Diesel Exhaust Among Non-Metal Miners.'' The 
Board will provide NIOSH with an assessment of the scientific 
quality of the draft protocol, including a review of the stated 
objectives of the study and the methods proposed to achieve those 
objectives.
    Given the public interest in this study, the Board and NIOSH 
will review the draft protocol as follows:
    1. On January 14, 1996, the Board will begin its review of the 
draft protocol.
    2. Copies of the draft protocol are available from Michael 
Attfield, Ph.D., NIOSH Project Director, NIOSH, Division of 
Respiratory Disease Studies, Mail Stop 234, 1095 Willowdale Road, 
Morgantown, West Virginia 26505-2888; (304)285-5751; Internet 
address [email protected]; and from the NIOSH Home Page at 
http://www.cdc.gov/niosh/homepage.html.
    3. The public is invited to submit written comments on the draft 
protocol to NIOSH through January 31, 1997. All written comments 
should be submitted to Dr. Attfield at the above address. At this 
January 14, 1997 meeting of the Board, members of the public may 
make oral comments up to five minutes in length if time allows.
    4. NIOSH will revise the draft protocol after receipt of all 
written and oral comments. A revised protocol will thereafter be 
made available to the Board and to any interested person. The 
availability of the revised protocol will be announced in the 
Federal Register and on the NIOSH Home Page.
    5. In approximately 90 days following the January 14, 1997 
meeting, the Board will reconvene at a public meeting (to be 
announced in the Federal Register) to consider the revised protocol 
and any written comments provided to NIOSH. The Board will provide 
comments and recommendations to NIOSH on the revised protocol.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Bryan D. Hardin, Ph.D., 
Executive Secretary, BSC, NIOSH, CDC, 200 Independence Avenue, SW, 
Humphrey Building, Washington, DC 20201, telephone (202) 205-8556.

    Dated: December 11, 1996.
John C. Burckhardt,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention (CDC).
[FR Doc. 96-31948 Filed 12-13-96; 8:45 am]
BILLING CODE 4163-19-P